This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Mattsson-Carlgren, N. et al. Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid immunotherapies. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2023.4596 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wood, H. Tau aids selection of anti-amyloid drug recipients. Nat Rev Neurol 20, 63 (2024). https://doi.org/10.1038/s41582-023-00925-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-023-00925-9